6951 - 6960 of 9030 Results
Title
Year
-
OPENTitle: Screening of the glucocerebrosidase (GBA) gene in South Africans of African ancestry with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 88Issue #:Start Page: 156.e11End Page: 156.e14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.12.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7085451Citation Count: 20
-
OPENTitle: Reduced serum interleukin-2 associates with higher motor severity and along with CD4 T cell alterations may be an early event in isolated REM Sleep Behaviour DisorderJournal Name: Brain, Behavior, & Immunity - HealthPublisher: Elsevier BVVol: 54Issue #:Start Page: 101257End Page: 101257Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbih.2026.101257Best OA location URL: https://doi.org/10.1016/j.bbih.2026.101257Citation Count: 0
- Comprehensive Analysis of Familial Parkinsonism Genes in Rapid‐Eye‐Movement Sleep Behavior Disorder2020OPENTitle: Comprehensive Analysis of Familial Parkinsonism Genes in Rapid‐Eye‐Movement Sleep Behavior DisorderJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 235End Page: 240Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28318Best OA location URL: http://hdl.handle.net/11380/1227849Citation Count: 17
-
OPENTitle: A common mechanism of singular gene choice is revealed by broadly expressed odorant receptor transgenes within the olfactory epitheliumJournal Name: Cell ReportsPublisher: Elsevier BVVol: 44Issue #: 7Start Page: 115955End Page: 115955Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2025.115955Best OA location URL: https://www.cell.com/cell-reports/pdf/S2211-1247(25)00726-0.pdfCitation Count: 3
-
OPENTitle: Identification of risk genes for Alzheimer’s disease by gene embeddingJournal Name: Cell GenomicsPublisher: Elsevier BVVol: 2Issue #: 9Start Page: 100162End Page: 100162Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xgen.2022.100162Best OA location URL: https://doi.org/10.1016/j.xgen.2022.100162Citation Count: 26
- PET imaging of alpha-synuclein: from radiotracer design through in vitro and in vivo translation2026OPENTitle: PET imaging of alpha-synuclein: from radiotracer design through in vitro and in vivo translationJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 53Issue #: 6Start Page: 4211End Page: 4239Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00259-025-07695-0Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC13121216/Citation Count: 2
-
OPENTitle: Is Freezing of Gait in Parkinson's Disease a Result of Multiple Gait Impairments? Implications for TreatmentJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/459321Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/459321.pdfCitation Count: 113
- PTPA variants are rare in early-onset and familial Parkinson’s disease2023RESTRICTEDTitle: PTPA variants are rare in early-onset and familial Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 12Start Page: 9End Page: 44Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awad244Citation Count: 1
- Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial2019RESTRICTEDTitle: Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 145End Page: 154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30405-8Citation Count: 119
- Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM502024OPENTitle: Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM50Journal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.99914.3Best OA location URL: https://doi.org/10.7554/elife.99914.3Citation Count: 1